Over 10 years experience of Traceability Solutions
By pharmatrax
Category: Technoloy
No Comments
Jennifer Bradford and Matthew Metherell consider the success and potential of artificial intelligence in clinical research and the impact of machine learning on clinical trials…
By pharmatrax
Category: News
No Comments
These are tough times around the world when it comes to regulating flawed medicines that are banned from the marketplace. Last month, the Washington Post reported details from…
By pharmatrax
Category: Technoloy
No Comments
David J. Balderson, vice president, Global Safety Operations at Sciformix – a Covance company – examines how automation is helping to reduce negative drug outcomes.…
By pharmatrax
Category: News
No Comments
Emcure Pharmaceuticals has had its share of run-ins with the FDA in the past over the sterility of one of its Indian manufacturing plants. Now,…
By pharmatrax
Category: Technoloy
No Comments
David Bennett, life sciences advisor, Mind Foundry explains why it’s prime time for the pharma industry to embrace data. AI and machine learning are rapidly entering the…
By pharmatrax
Category: News
No Comments
WASHINGTON, DC (WICS/WRSP) — A blood pressure medicine that has dealt with at least four recalls this year is facing yet another. This time, the recall…
By pharmatrax
Category: Technoloy
No Comments
New smart building technologies are helping pharmaceutical companies enhance productivity without compromising on compliance or quality. However, to maximise the available opportunities, companies need to…
By pharmatrax
Category: Technoloy
No Comments
Though the analysis and exchange of digitized medical data have the power to drive major progress in healthcare, actual transformation will not happen until data…
By pharmatrax
Category: Technoloy
No Comments
Artificial intelligence (AI) and machine learning are driving a great deal of the healthcare innovation in precision medicine, according to a new Chilmark Research report. The report reveals…
By pharmatrax
Category: News
No Comments
Computer model predicts worsening cognitive scores, opening door to the use of machine learning in the selection of participants in Alzheimer’s disease trials. One of…